Anne brings over 40 years of entrepreneurial and intrapreneurial experience within the biopharma and medical device industries. Most recently she was the Founder, President and CEO of Inspira Therapeutics, Inc., a biopharmaceutical company developing novel tolerizing vaccines to treat autoimmune disease, including type 1 Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.
As one of the biopharmaceutical and medical device industry’s most recognized entrepreneurial leaders, Anne’s inspirational vision, effective team building, and purposeful leadership have created forward-thinking companies driving ground-breaking innovation and development. She has previously led new product launches and collaborated with top executives throughout the world to ensure success for several billion-dollar brands. These efforts include new treatments and diagnostics for some of the world’s most pernicious diseases, such as HIV, epilepsy, depression, overactive bladder, breast cancer, IBS, stroke, and type 1 diabetes. She earned an MSE in Biomaterials and Macromolecular Science and Engineering from the University of Michigan and an MBA in International Marketing and Finance from Boston University, both with high honors. She has also received the International Biomaterials Award for Distinguished Research.